Neogen Chemicals Ltd

Neogen Chemicals Ltd

₹ 1,644 4.02%
20 May 9:09 a.m.
About

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

Key Points

About
The company manufactures Bromine and Lithium-based chemical compounds.It also manufactures advanced intermediates in Pharma / Agro / Flavours and Fragrances. [1] Neogen is the largest importer of Lithium Carbonate & Lithium Hydroxide for last 3 decades.[2]

  • Market Cap 4,502 Cr.
  • Current Price 1,644
  • High / Low 1,883 / 967
  • Stock P/E 95.9
  • Book Value 324
  • Dividend Yield 0.06 %
  • ROCE 9.99 %
  • ROE 5.65 %
  • Face Value 10.0

Pros

  • Promoter holding has increased by 1.78% over last quarter.
  • Company's median sales growth is 19.3% of last 10 years
  • Company's working capital requirements have reduced from 156 days to 110 days

Cons

  • Stock is trading at 4.88 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 6.51% over last 3 years.
  • Dividend payout has been low at 7.96% of profits over last 3 years
  • Company has high debtors of 152 days.
  • Promoter holding has decreased over last 3 years: -7.18%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
204 170 168 164 210 176 193 200 204 185 207 216 249
171 141 142 143 172 145 157 163 163 150 172 179 203
Operating Profit 33 29 26 22 38 32 36 38 41 35 35 36 45
OPM % 16% 17% 16% 13% 18% 18% 19% 19% 20% 19% 17% 17% 18%
2 2 2 2 3 3 2 2 -11 3 4 4 4
Interest 9 11 11 11 10 10 12 13 16 14 21 23 23
Depreciation 4 5 5 6 6 6 7 7 6 5 6 6 6
Profit before tax 21 16 12 7 25 19 20 20 8 19 12 12 20
Tax % 31% 28% 26% 69% 24% 26% 25% 28% 33% 25% 24% 26% 26%
14 11 9 2 19 14 15 14 5 14 9 9 15
EPS in Rs 5.75 4.58 3.66 0.85 7.30 5.28 5.63 5.46 1.97 5.39 3.53 3.32 5.56
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
84 100 110 161 239 306 336 487 686 701 774 855
71 86 90 132 196 248 272 401 575 585 627 704
Operating Profit 13 14 20 29 43 58 64 87 112 116 147 151
OPM % 15% 14% 18% 18% 18% 19% 19% 18% 16% 17% 19% 18%
1 0 0 1 1 0 1 1 5 8 -4 16
Interest 5 5 8 10 12 12 14 19 29 42 51 80
Depreciation 1 1 1 2 3 5 7 12 16 23 26 24
Profit before tax 8 8 12 18 29 41 44 57 71 59 66 63
Tax % 37% 39% 33% 39% 28% 30% 29% 22% 30% 31% 27% 26%
5 5 8 11 21 29 31 45 50 41 48 47
EPS in Rs 11.31 2.59 3.88 5.34 10.48 12.33 13.47 17.93 20.07 15.59 18.35 17.80
Dividend Payout % 18% 77% 26% 19% 14% 16% 17% 15% 15% 13% 5% 6%
Compounded Sales Growth
10 Years: 24%
5 Years: 21%
3 Years: 8%
TTM: 11%
Compounded Profit Growth
10 Years: 25%
5 Years: 8%
3 Years: -2%
TTM: -19%
Stock Price CAGR
10 Years: %
5 Years: 10%
3 Years: 0%
1 Year: 3%
Return on Equity
10 Years: 10%
5 Years: 8%
3 Years: 7%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4 20 20 20 20 23 23 25 25 26 26 26
Reserves 19 8 22 31 50 133 160 414 458 740 782 827
24 26 69 82 120 137 222 229 370 409 474 736
21 27 41 48 56 61 87 131 202 230 338 586
Total Liabilities 69 80 152 181 247 355 492 800 1,054 1,405 1,621 2,176
13 17 56 67 83 111 127 285 347 361 228 294
CWIP 0 1 1 1 0 3 115 11 36 56 28 161
Investments -0 -0 0 0 0 0 0 81 77 5 193 307
55 62 94 112 163 242 250 423 594 983 1,173 1,413
Total Assets 69 80 152 181 247 355 492 800 1,054 1,405 1,621 2,176

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
9 9 0 12 -4 -34 83 1 -30 -134 199 -99
-2 -4 -33 -13 -20 -29 -134 -146 -94 -129 -188 -35
-6 -4 33 -0 24 62 51 188 100 226 -12 137
Net Cash Flow 1 0 1 -1 0 -1 -0 44 -25 -37 -2 3
Free Cash Flow 7 4 -32 -1 -24 -63 -52 -65 -134 -207 167 -129
CFO/OP 89% 83% 21% 54% 4% -37% 146% 13% -17% -107% 144% -53%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 78 58 107 94 93 90 85 82 94 147 94 152
Inventory Days 178 190 228 192 188 257 211 258 275 353 265 425
Days Payable 120 130 177 141 111 71 122 131 147 134 220 325
Cash Conversion Cycle 136 117 158 145 169 276 174 209 223 366 138 252
Working Capital Days 140 126 67 49 63 96 67 111 80 190 169 110
ROCE % 27% 26% 23% 23% 26% 22% 17% 14% 13% 10% 11% 10%

Insights

In beta
Mar 2012 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2027 (P)
Organic Chemicals Total Reactor Capacity
m3

Log in to view insights

Please log in to see hidden values.

Login
Inorganic Chemicals Total Capacity
MTPA
Export Footprint
Countries
Total Number of Products Developed
Number
Mahape Facility Organic Capacity Utilization
%
Electrolyte Solutions Capacity
MT/Annum
Vadodara Facility Organic Capacity Utilization
%
Lithium Electrolyte Salt Capacity
MT/Annum

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Apr 2026
60.18% 56.89% 56.89% 56.89% 51.22% 51.22% 51.22% 51.22% 51.22% 51.22% 51.22% 53.00%
4.25% 4.51% 4.56% 4.65% 8.17% 7.73% 7.79% 7.35% 5.15% 4.57% 4.46% 4.29%
20.25% 22.85% 22.14% 22.54% 22.48% 22.52% 22.75% 22.96% 25.22% 21.99% 22.65% 21.67%
15.32% 15.75% 16.42% 15.93% 18.12% 18.51% 18.22% 18.45% 18.40% 22.21% 21.67% 21.05%
No. of Shareholders 45,30047,01848,35646,69846,47047,65146,10446,32145,71047,88454,33256,330

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls